Advertisement

Index by author

August 01, 1995; Volume 23,Issue 8

A

  1. Ader, J C

    1. Structural determination of a glucuronide conjugate of flucytosine in humans.
      N Chouini-Lalanne, M C Malet-Martino, V Gilard, J C Ader and R Martino
      Drug Metabolism and Disposition August 1995, 23 (8) 813-817;

  2. Aigbirhio, F I

    1. Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;

  3. Ali, S F

    1. Placental transfer and fetal disposition of 2',3'-dideoxycytidine and 2',3'-dideoxyinosine in the rhesus monkey.
      J A Sandberg, Z Binienda, G Lipe, L M Rose, W B Parker, S F Ali and W Slikker
      Drug Metabolism and Disposition August 1995, 23 (8) 881-884;

  4. Anders, M W

    1. Gas-uptake pharmacokinetics and metabolism of 2-chloro-1,1,1,2-tetrafluoroethane (HCFC-124) in the rat, mouse, and hamster.
      G D Loizou and M W Anders
      Drug Metabolism and Disposition August 1995, 23 (8) 875-880;

  5. Anderson, K

    1. Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;

B

  1. Benet, L Z

    1. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
      L M Bornheim, K Y Kim, J Li, B Y Perotti and L Z Benet
      Drug Metabolism and Disposition August 1995, 23 (8) 825-831;

  2. Binienda, Z

    1. Placental transfer and fetal disposition of 2',3'-dideoxycytidine and 2',3'-dideoxyinosine in the rhesus monkey.
      J A Sandberg, Z Binienda, G Lipe, L M Rose, W B Parker, S F Ali and W Slikker
      Drug Metabolism and Disposition August 1995, 23 (8) 881-884;

  3. Birner, G

    1. The role of cytochrome P4503A1/2 in the sex-specific sulfoxidation of the hexachlorobutadiene metabolite, N-acetyl-S-(pentachlorobutadienyl)-L-cysteine in rats.
      M Werner, G Birner and W Dekant
      Drug Metabolism and Disposition August 1995, 23 (8) 861-868;

  4. Blake, T

    1. Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;

  5. Bornheim, L M

    1. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
      L M Bornheim, K Y Kim, J Li, B Y Perotti and L Z Benet
      Drug Metabolism and Disposition August 1995, 23 (8) 825-831;

C

  1. Cheng, L K

    1. Human metabolism of dolasetron mesylate, a 5-HT3 receptor antagonist.
      M K Reith, G D Sproles and L K Cheng
      Drug Metabolism and Disposition August 1995, 23 (8) 806-812;

  2. Cho, J H

    1. In vivo modification of 3'-phosphoadenosine 5'-phosphosulfate and sulfate by infusion of sodium sulfate, cysteine, and methionine.
      H J Kim, C Madhu, J H Cho and C D Klaassen
      Drug Metabolism and Disposition August 1995, 23 (8) 840-845;

  3. Chouini-Lalanne, N

    1. Structural determination of a glucuronide conjugate of flucytosine in humans.
      N Chouini-Lalanne, M C Malet-Martino, V Gilard, J C Ader and R Martino
      Drug Metabolism and Disposition August 1995, 23 (8) 813-817;

  4. Crowley, J R

    1. Mechanism-based inactivation of rat liver cytochrome P4502B1 by phencyclidine and its oxidative product, the iminium ion.
      J R Crowley and P F Hollenberg
      Drug Metabolism and Disposition August 1995, 23 (8) 786-793;

D

  1. Dekant, W

    1. The role of cytochrome P4503A1/2 in the sex-specific sulfoxidation of the hexachlorobutadiene metabolite, N-acetyl-S-(pentachlorobutadienyl)-L-cysteine in rats.
      M Werner, G Birner and W Dekant
      Drug Metabolism and Disposition August 1995, 23 (8) 861-868;

  2. Dreyer, G

    1. Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;

  3. Duescher, R J

    1. Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity.
      L H Lash, Y Xu, A A Elfarra, R J Duescher and J C Parker
      Drug Metabolism and Disposition August 1995, 23 (8) 846-853;

E

  1. Elfarra, A A

    1. Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity.
      L H Lash, Y Xu, A A Elfarra, R J Duescher and J C Parker
      Drug Metabolism and Disposition August 1995, 23 (8) 846-853;

F

  1. Facchine, K L

    1. An improved HPLC assay for the assessment of liver slice metabolic viability using 7-ethoxycoumarin.
      J S Walsh, J E Patanella, K A Halm and K L Facchine
      Drug Metabolism and Disposition August 1995, 23 (8) 869-874;

  2. Fong, K L

    1. Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;

  3. Freemantle, C A

    1. Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;

  4. Fukuyama, T

    1. Effect of liver intoxication by carbon tetrachloride on hepatic local disposition of oxacillin using moment characteristics as index.
      H Yasui, K Yamaoka, T Fukuyama and T Nakagawa
      Drug Metabolism and Disposition August 1995, 23 (8) 779-785;

G

  1. Garver, E

    1. Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;

  2. Gilard, V

    1. Structural determination of a glucuronide conjugate of flucytosine in humans.
      N Chouini-Lalanne, M C Malet-Martino, V Gilard, J C Ader and R Martino
      Drug Metabolism and Disposition August 1995, 23 (8) 813-817;

H

  1. Halm, K A

    1. An improved HPLC assay for the assessment of liver slice metabolic viability using 7-ethoxycoumarin.
      J S Walsh, J E Patanella, K A Halm and K L Facchine
      Drug Metabolism and Disposition August 1995, 23 (8) 869-874;

  2. Heys, R

    1. Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;

  3. Hollenberg, P F

    1. Mechanism-based inactivation of rat liver cytochrome P4502B1 by phencyclidine and its oxidative product, the iminium ion.
      J R Crowley and P F Hollenberg
      Drug Metabolism and Disposition August 1995, 23 (8) 786-793;

J

  1. Jones, T

    1. Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;

  2. Joseph, G

    1. Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;

K

  1. Kim, H

    1. 3-Methylcholanthrene and pyridine effects on CYP1A1 and CYP1A2 expression in rat renal tissue.
      H Kim, S Reddy and R F Novak
      Drug Metabolism and Disposition August 1995, 23 (8) 818-824;

  2. Kim, H J

    1. In vivo modification of 3'-phosphoadenosine 5'-phosphosulfate and sulfate by infusion of sodium sulfate, cysteine, and methionine.
      H J Kim, C Madhu, J H Cho and C D Klaassen
      Drug Metabolism and Disposition August 1995, 23 (8) 840-845;

  3. Kim, K Y

    1. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
      L M Bornheim, K Y Kim, J Li, B Y Perotti and L Z Benet
      Drug Metabolism and Disposition August 1995, 23 (8) 825-831;

  4. Klaassen, C D

    1. In vivo modification of 3'-phosphoadenosine 5'-phosphosulfate and sulfate by infusion of sodium sulfate, cysteine, and methionine.
      H J Kim, C Madhu, J H Cho and C D Klaassen
      Drug Metabolism and Disposition August 1995, 23 (8) 840-845;

L

  1. Lash, L H

    1. Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity.
      L H Lash, Y Xu, A A Elfarra, R J Duescher and J C Parker
      Drug Metabolism and Disposition August 1995, 23 (8) 846-853;

  2. Li, J

    1. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
      L M Bornheim, K Y Kim, J Li, B Y Perotti and L Z Benet
      Drug Metabolism and Disposition August 1995, 23 (8) 825-831;

  3. Lipe, G

    1. Placental transfer and fetal disposition of 2',3'-dideoxycytidine and 2',3'-dideoxyinosine in the rhesus monkey.
      J A Sandberg, Z Binienda, G Lipe, L M Rose, W B Parker, S F Ali and W Slikker
      Drug Metabolism and Disposition August 1995, 23 (8) 881-884;

  4. Loizou, G D

    1. Gas-uptake pharmacokinetics and metabolism of 2-chloro-1,1,1,2-tetrafluoroethane (HCFC-124) in the rat, mouse, and hamster.
      G D Loizou and M W Anders
      Drug Metabolism and Disposition August 1995, 23 (8) 875-880;

M

  1. Macleod, M C

    1. Toxicity and metabolism in mice of 2,6-dithiopurine, a potential chemopreventive agent.
      W G Qing, K L Powell, G Stoica, C L Szumlanski, R M Weinshilboum and M C Macleod
      Drug Metabolism and Disposition August 1995, 23 (8) 854-860;

  2. Madhu, C

    1. In vivo modification of 3'-phosphoadenosine 5'-phosphosulfate and sulfate by infusion of sodium sulfate, cysteine, and methionine.
      H J Kim, C Madhu, J H Cho and C D Klaassen
      Drug Metabolism and Disposition August 1995, 23 (8) 840-845;

  3. Malet-Martino, M C

    1. Structural determination of a glucuronide conjugate of flucytosine in humans.
      N Chouini-Lalanne, M C Malet-Martino, V Gilard, J C Ader and R Martino
      Drug Metabolism and Disposition August 1995, 23 (8) 813-817;

  4. Martino, R

    1. Structural determination of a glucuronide conjugate of flucytosine in humans.
      N Chouini-Lalanne, M C Malet-Martino, V Gilard, J C Ader and R Martino
      Drug Metabolism and Disposition August 1995, 23 (8) 813-817;

N

  1. Nakagawa, T

    1. Effect of liver intoxication by carbon tetrachloride on hepatic local disposition of oxacillin using moment characteristics as index.
      H Yasui, K Yamaoka, T Fukuyama and T Nakagawa
      Drug Metabolism and Disposition August 1995, 23 (8) 779-785;

  2. Novak, R F

    1. 3-Methylcholanthrene and pyridine effects on CYP1A1 and CYP1A2 expression in rat renal tissue.
      H Kim, S Reddy and R F Novak
      Drug Metabolism and Disposition August 1995, 23 (8) 818-824;

O

  1. Olsson, P

    1. Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;

P

  1. Page, B C

    1. Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;

  2. Parker, J C

    1. Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity.
      L H Lash, Y Xu, A A Elfarra, R J Duescher and J C Parker
      Drug Metabolism and Disposition August 1995, 23 (8) 846-853;

  3. Parker, W B

    1. Placental transfer and fetal disposition of 2',3'-dideoxycytidine and 2',3'-dideoxyinosine in the rhesus monkey.
      J A Sandberg, Z Binienda, G Lipe, L M Rose, W B Parker, S F Ali and W Slikker
      Drug Metabolism and Disposition August 1995, 23 (8) 881-884;

  4. Patanella, J E

    1. An improved HPLC assay for the assessment of liver slice metabolic viability using 7-ethoxycoumarin.
      J S Walsh, J E Patanella, K A Halm and K L Facchine
      Drug Metabolism and Disposition August 1995, 23 (8) 869-874;

  5. Perotti, B Y

    1. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
      L M Bornheim, K Y Kim, J Li, B Y Perotti and L Z Benet
      Drug Metabolism and Disposition August 1995, 23 (8) 825-831;

  6. Pike, V W

    1. Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;

  7. Potts, W

    1. Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;

  8. Powell, K L

    1. Toxicity and metabolism in mice of 2,6-dithiopurine, a potential chemopreventive agent.
      W G Qing, K L Powell, G Stoica, C L Szumlanski, R M Weinshilboum and M C Macleod
      Drug Metabolism and Disposition August 1995, 23 (8) 854-860;

Q

  1. Qing, W G

    1. Toxicity and metabolism in mice of 2,6-dithiopurine, a potential chemopreventive agent.
      W G Qing, K L Powell, G Stoica, C L Szumlanski, R M Weinshilboum and M C Macleod
      Drug Metabolism and Disposition August 1995, 23 (8) 854-860;

R

  1. Reddy, S

    1. 3-Methylcholanthrene and pyridine effects on CYP1A1 and CYP1A2 expression in rat renal tissue.
      H Kim, S Reddy and R F Novak
      Drug Metabolism and Disposition August 1995, 23 (8) 818-824;

  2. Reith, M K

    1. Human metabolism of dolasetron mesylate, a 5-HT3 receptor antagonist.
      M K Reith, G D Sproles and L K Cheng
      Drug Metabolism and Disposition August 1995, 23 (8) 806-812;

  3. Rhodes, C G

    1. Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;

  4. Rose, L M

    1. Placental transfer and fetal disposition of 2',3'-dideoxycytidine and 2',3'-dideoxyinosine in the rhesus monkey.
      J A Sandberg, Z Binienda, G Lipe, L M Rose, W B Parker, S F Ali and W Slikker
      Drug Metabolism and Disposition August 1995, 23 (8) 881-884;

S

  1. Sandberg, J A

    1. Placental transfer and fetal disposition of 2',3'-dideoxycytidine and 2',3'-dideoxyinosine in the rhesus monkey.
      J A Sandberg, Z Binienda, G Lipe, L M Rose, W B Parker, S F Ali and W Slikker
      Drug Metabolism and Disposition August 1995, 23 (8) 881-884;

  2. Semple, H A

    1. Interaction between propranolol and amino acids in the single-pass isolated, perfused rat liver.
      H A Semple and F Xia
      Drug Metabolism and Disposition August 1995, 23 (8) 794-798;

  3. Shu, A

    1. Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;

  4. Slikker, W

    1. Placental transfer and fetal disposition of 2',3'-dideoxycytidine and 2',3'-dideoxyinosine in the rhesus monkey.
      J A Sandberg, Z Binienda, G Lipe, L M Rose, W B Parker, S F Ali and W Slikker
      Drug Metabolism and Disposition August 1995, 23 (8) 881-884;

  5. Sproles, G D

    1. Human metabolism of dolasetron mesylate, a 5-HT3 receptor antagonist.
      M K Reith, G D Sproles and L K Cheng
      Drug Metabolism and Disposition August 1995, 23 (8) 806-812;

  6. Stoica, G

    1. Toxicity and metabolism in mice of 2,6-dithiopurine, a potential chemopreventive agent.
      W G Qing, K L Powell, G Stoica, C L Szumlanski, R M Weinshilboum and M C Macleod
      Drug Metabolism and Disposition August 1995, 23 (8) 854-860;

  7. Szumlanski, C L

    1. Toxicity and metabolism in mice of 2,6-dithiopurine, a potential chemopreventive agent.
      W G Qing, K L Powell, G Stoica, C L Szumlanski, R M Weinshilboum and M C Macleod
      Drug Metabolism and Disposition August 1995, 23 (8) 854-860;

T

  1. Tanner, R J

    1. Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;

V

  1. van Horn, R

    1. Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;

  2. Ventresca, G P

    1. Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;

W

  1. Walsh, J S

    1. An improved HPLC assay for the assessment of liver slice metabolic viability using 7-ethoxycoumarin.
      J S Walsh, J E Patanella, K A Halm and K L Facchine
      Drug Metabolism and Disposition August 1995, 23 (8) 869-874;

  2. Waters, S L

    1. Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;

  3. Weinshilboum, R M

    1. Toxicity and metabolism in mice of 2,6-dithiopurine, a potential chemopreventive agent.
      W G Qing, K L Powell, G Stoica, C L Szumlanski, R M Weinshilboum and M C Macleod
      Drug Metabolism and Disposition August 1995, 23 (8) 854-860;

  4. Werner, M

    1. The role of cytochrome P4503A1/2 in the sex-specific sulfoxidation of the hexachlorobutadiene metabolite, N-acetyl-S-(pentachlorobutadienyl)-L-cysteine in rats.
      M Werner, G Birner and W Dekant
      Drug Metabolism and Disposition August 1995, 23 (8) 861-868;

X

  1. Xia, F

    1. Interaction between propranolol and amino acids in the single-pass isolated, perfused rat liver.
      H A Semple and F Xia
      Drug Metabolism and Disposition August 1995, 23 (8) 794-798;

  2. Xu, Y

    1. Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity.
      L H Lash, Y Xu, A A Elfarra, R J Duescher and J C Parker
      Drug Metabolism and Disposition August 1995, 23 (8) 846-853;

Y

  1. Yamaoka, K

    1. Effect of liver intoxication by carbon tetrachloride on hepatic local disposition of oxacillin using moment characteristics as index.
      H Yasui, K Yamaoka, T Fukuyama and T Nakagawa
      Drug Metabolism and Disposition August 1995, 23 (8) 779-785;

  2. Yasui, H

    1. Effect of liver intoxication by carbon tetrachloride on hepatic local disposition of oxacillin using moment characteristics as index.
      H Yasui, K Yamaoka, T Fukuyama and T Nakagawa
      Drug Metabolism and Disposition August 1995, 23 (8) 779-785;
Back to top

In this issue